Position in ANVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$390
+$368 QoQ
Shares Held
210
+2000.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSAIC HOLDINGS, INC. holds $237,726,632 across 405 Biotechnology names. ANVS ranks #335 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
90,236 | $28,522,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,586 | $24,630,851 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
372,588 | $20,469,983 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
217,577 | $16,205,134 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
176,973 | $13,851,674 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
45,298 | $13,636,055 | |
| 7 | VCEL |
Vericel Corp
|
182,038 | $8,098,869 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,423 | $7,746,234 |
All Filings in ANVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $390 | 210 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $22 | 10 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $726 | 210 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $434 | 210 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,469 | 677 | Shares | Defined | 2025-09-04 | |
| 2025-03-31 | $903 | 602 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,525 | 502 | Shares | Defined | 2025-06-06 | |
| 2024-09-30 | $9,672 | 1,200 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,344 | 1,275 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $14,280 | 1,200 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $22,440 | 1,200 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $11,388 | 1,200 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $30,809 | 2,156 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $33,223 | 2,156 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $45,205 | 3,366 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $44,936 | 3,280 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,473 | 2,070 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $38,314 | 2,870 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $151,081 | 8,594 | Shares | Defined | 2022-02-03 | |
| 2021-09-30 | $349,313 | 11,002 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $149,080 | 1,742 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $117,180 | 4,200 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $55,765 | 7,396 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $37,681 | 7,834 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,848 | 425 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,275 | 425 | Shares | Defined | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||